FDA Drug recall D-1279-2015
COMBIVENT RESPIMAT (ipratropium bromide and albuterol) Inhalation Spray, 20 mcg/100 mcg per actuation*, 4 Grams, 120 Metered Doses per inha…
- FDA Drug
- Class II
- terminated
- Published 2015-08-05
On 2015-08-05 the FDA classified a Class II recall of COMBIVENT RESPIMAT (ipratropium bromide and albuterol) Inhalation Spray, 20 mcg/100 mcg per actuation*, 4 Grams, 120 Metered Doses per inha… by Boehringer Ingelheim Roxane, citing defective Delivery System: Inhalers do not spray properly, emitting either no spray or a short transient spray.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1279-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-07-24 |
| Published | 2015-08-05 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Boehringer Ingelheim Roxane |
| Distribution | US |
Product
COMBIVENT RESPIMAT (ipratropium bromide and albuterol) Inhalation Spray, 20 mcg/100 mcg per actuation*, 4 Grams, 120 Metered Doses per inhaler, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Made in Germany, NDC 0597-0024-02.
Reason
Defective Delivery System: Inhalers do not spray properly, emitting either no spray or a short transient spray.
Identifiers
| ndc | 0597-0024-02 |
|---|---|
| code_info | Lot #: 408267, Exp 11/17 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1279-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.